Acceleron and Celgene partner to co-develop and commercialize Acceleron's preclinical anemia candidate ACE-536

Acceleron Pharma Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Celgene Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$25,472.9m on 08/05/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced